Congratulations to Sam El-Osta, Trisha Peel and Patrick Kwan on NHMRC clinical trial funding

L-R: Prof Sam El-Osta, A/Prof Trisha Peel & Prof Patrick Kwan
were awarded NHMRC CTCS grants, announced 24 May 2022.

Central Clinical School's excellence in clinical trials has been recognised once again with three of our researchers successful in the latest round of the NHMRC Clinical Trials and Cohort Studies Scheme funding, announced on 24 May.

Congratulations to Professor Sam El-Osta, Associate Professor Trisha Peel and Professor Patrick Kwan on their successful applications. A/Prof Peel was successful earlier this year for the CALIPSO project under the MRFF RCRDUN scheme.

Together, the three grants total more than $11.7 million - 15.5% of the $75.3 million funding allocated to the 33 successful trials in this round - and cover critical health issues including diabetes, antimicrobial resistance, epilepsy and intensive care.

Trial of new hepatitis care model aims to raise cure rates

Dr Joseph Doyle

by Anne Crawford

130,000 people live with untreated hepatitis C (HCV) in Australia. Direct-acting antiviral treatment marked a new era in HCV treatment and has the potential to eliminate the disease as a public health threat. But although curative treatment, which targets specific steps within the hepatitis life-cycle, has been available as a PBS-funded therapy in Australia for nearly three years, the number of people commencing it is falling.

In particular, people who inject drugs (PWID), who have the highest burden of hepatitis, can be difficult to engage in traditional models of care. It currently takes several visits to doctors to test, confirm, and start people on curative HCV treatment.

Dr Joseph Doyle from the Department of Infectious Diseases has received a $1.459 million Clinical Trials and Cohort Studies grant from the National Health and Medical Research Council to conduct a paradigm-changing trial assessing the clinical and cost-effectiveness of a same-visit HCV testing and treatment model of care for PWID.

Congratulations to our 2019 NHMRC Ideas and CTCS grant winners!

2019 CCS Ideas and Clinical Trials and Cohort Studies grant recipients.
L-R, upper row: Catherine Carmichael, Ross Dickins, Justin Hamilton,
Christoph Hagemeyer.  L-R lower row: Phil Kantharidis,
Marcus Robinson, Joseph Doyle, Paul Myles

Congratulations to our National Health and Medical Research Council (NHMRC) Ideas/Clinical Trials and Cohort Studies (CTCS) grant recipients in Central Clinical School (CCS)!

CCS researchers have been awarded a total of $12.7 million across 8 grants (6 Ideas, 2 CTCS). CCS areas of expertise which have been funded this round range across the discipline areas of blood diseases, diabetes, infectious diseases, immunology and surgery. Funding for these grants will begin in 2020.

Monash University has been awarded more than $76 million in this round of National Health and Medical Research Council (NHMRC) funding. Link

Researcher awarded $5 million by NHMRC for trial into post-surgery infection drug

Tranexamic acid (TXA) is used to reduce
 excessive bleeding. There is also evidence that
 TXA has immune-protective effects.

by Anne Crawford

Professor Paul Myles, Director of the Department of Anaesthesia and Perioperative Medicine in Central Clinical School and at The Alfred, has been awarded a $5.19 million Clinical Trials and Cohort Studies (CTCS) grant from the National Health and Medical Research Council (NHMRC) to conduct an international trial of a medication that could prevent infections after surgery.